Advertisement
U.S. Markets closed
S&P Futures
5,885.75 -10.50 (-0.18%) Dow Futures
43,121.00 -56.00 (-0.13%) Nasdaq Futures
20,462.50 -57.00 (-0.28%) Russell 2000 Futures
2,249.50 -6.00 (-0.27%) Crude Oil
70.30 -0.26 (-0.37%) Gold
2,744.50 +5.60 (+0.20%)
Dogwood Therapeutics, Inc. (DWTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 3.8600 |
| Open | 3.8600 |
| Bid | 4.3100 x 100 |
| Ask | 4.2400 x 100 |
| Day's Range | 3.6450 - 4.0989 |
| 52 Week Range | 2.5010 - 26.0000 |
| Volume | |
| Avg. Volume | 88,407 |
| Market Cap | 5.262M |
| Beta (5Y Monthly) | 1.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.7500 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53.83 |
Zacks Small Cap ResearchDWTX: Virios Therapeutics Becomes Dogwood Therapeutics; Focus on Chemotherapy-Induced Neuropathic Pain…
By David Bautz, PhD NASDAQ:DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Virios Combines with Wex Pharmaceuticals to Form Dogwood Therapeutics On October 7, 2024, Virios Therapeutics, Inc. (NASDAQ:VIRI) announced a business combination with privately-held Wex Pharmaceuticals, Inc. to form Dogwood Therapeutics, Inc. (NASDAQ:DWTX). The combined company will be focused on the clinical
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.